Literature DB >> 21946227

High-resolution detection of ¹³C multiplets from the conscious mouse brain by ex vivo NMR spectroscopy.

Isaac Marin-Valencia1, Levi B Good, Qian Ma, F Mark Jeffrey, Craig R Malloy, Juan M Pascual.   

Abstract

Glucose readily supplies the brain with the majority of carbon needed to sustain neurotransmitter production and utilization. The rate of brain glucose metabolism can be computed using (13)C nuclear magnetic resonance (NMR) spectroscopy by detecting changes in (13)C contents of products generated by cerebral metabolism. As previously observed, scalar coupling between adjacent (13)C carbons (multiplets) can provide additional information to (13)C contents for the computation of metabolic rates. Most NMR studies have been conducted in large animals (often under anesthesia) because the mass of the target organ is a limiting factor for NMR. Yet, despite the challengingly small size of the mouse brain, NMR studies are highly desirable because the mouse constitutes a common animal model for human neurological disorders. We have developed a method for the ex vivo resolution of NMR multiplets arising from the brain of an awake mouse after the infusion of [1,6-(13)C(2)]glucose. NMR spectra obtained by this method display favorable signal-to-noise ratios. With this infusion protocol, the (13)C multiplets of glutamate, glutamine, GABA and aspartate achieved steady state after 150 min. The method enables the accurate resolution of multiplets over time in the awake mouse brain. We anticipate that this method can be broadly applicable to compute brain fluxes in normal and transgenic mouse models of neurological disorders.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21946227      PMCID: PMC3221797          DOI: 10.1016/j.jneumeth.2011.09.006

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  26 in total

1.  Contribution of exogenous substrates to acetyl coenzyme A: measurement by 13C NMR under non-steady-state conditions.

Authors:  C R Malloy; J R Thompson; F M Jeffrey; A D Sherry
Journal:  Biochemistry       Date:  1990-07-24       Impact factor: 3.162

2.  Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity.

Authors:  N R Sibson; A Dhankhar; G F Mason; D L Rothman; K L Behar; R G Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

3.  High-sensitivity amino acid analysis: measurement of amino acid neurotransmitter in mouse brain.

Authors:  J Y Chang; P Martin; R Bernasconi; D G Braun
Journal:  FEBS Lett       Date:  1981-09-14       Impact factor: 4.124

4.  Glutamine synthetase in oligodendrocytes and astrocytes: new biochemical and immunocytochemical evidence.

Authors:  F A Tansey; M Farooq; W Cammer
Journal:  J Neurochem       Date:  1991-01       Impact factor: 5.372

5.  Trafficking of amino acids between neurons and glia in vivo. Effects of inhibition of glial metabolism by fluoroacetate.

Authors:  B Hassel; H Bachelard; P Jones; F Fonnum; U Sonnewald
Journal:  J Cereb Blood Flow Metab       Date:  1997-11       Impact factor: 6.200

6.  NMR spectroscopic study of cell cultures of astrocytes and neurons exposed to hypoxia: compartmentation of astrocyte metabolism.

Authors:  U Sonnewald; T B Müller; N Westergaard; G Unsgård; S B Petersen; A Schousboe
Journal:  Neurochem Int       Date:  1994-05       Impact factor: 3.921

7.  Transaminase reaction rates, transport activities and TCA cycle analysis by post-steady state 13C NMR.

Authors:  P M Robitaille; D P Rath; T E Skinner; A M Abduljalil; R L Hamlin
Journal:  Magn Reson Med       Date:  1993-08       Impact factor: 4.668

8.  Consequences of altered aspartate aminotransferase activity on 13C-glutamate labelling by the tricarboxylic acid cycle in intact rat hearts.

Authors:  R G Weiss; M D Stern; C P de Albuquerque; K Vandegaer; V P Chacko; G Gerstenblith
Journal:  Biochim Biophys Acta       Date:  1995-04-13

9.  Metabolic differences between primary cultures of astrocytes and neurons from cerebellum and cerebral cortex. Effects of fluorocitrate.

Authors:  B Hassel; N Westergaard; A Schousboe; F Fonnum
Journal:  Neurochem Res       Date:  1995-04       Impact factor: 3.996

10.  Altered brain glucose metabolism in transgenic-PFKL mice with elevated L-phosphofructokinase: in vivo NMR studies.

Authors:  M Peled-Kamar; H Degani; P Bendel; R Margalit; Y Groner
Journal:  Brain Res       Date:  1998-11-09       Impact factor: 3.252

View more
  5 in total

1.  Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement.

Authors:  Juan M Pascual; Peiying Liu; Deng Mao; Dorothy I Kelly; Ana Hernandez; Min Sheng; Levi B Good; Qian Ma; Isaac Marin-Valencia; Xuchen Zhang; Jason Y Park; Linda S Hynan; Peter Stavinoha; Charles R Roe; Hanzhang Lu
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

2.  A subset of synaptic transmission events is coupled to acetyl coenzyme A production.

Authors:  Vikram Jakkamsetti; Qian Ma; Juan M Pascual
Journal:  J Neurophysiol       Date:  2022-01-26       Impact factor: 2.714

3.  Hypermetabolic state in the 7-month-old triple transgenic mouse model of Alzheimer's disease and the effect of lipoic acid: a 13C-NMR study.

Authors:  Harsh Sancheti; Ishan Patil; Keiko Kanamori; Roberta Díaz Brinton; Wei Zhang; Ai-Ling Lin; Enrique Cadenas
Journal:  J Cereb Blood Flow Metab       Date:  2014-08-06       Impact factor: 6.200

4.  Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain.

Authors:  Isaac Marin-Valencia; Levi B Good; Qian Ma; Craig R Malloy; Juan M Pascual
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

Review 5.  Glucose Transporter Type I Deficiency (G1D) at 25 (1990-2015): Presumptions, Facts, and the Lives of Persons With This Rare Disease.

Authors:  Juan M Pascual; Gabriel M Ronen
Journal:  Pediatr Neurol       Date:  2015-08-10       Impact factor: 3.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.